The University of Texas MD Anderson Cancer Center
Gynecologic Oncology fellowship · Houston, TX · Program website
Incomplete roster. The trainee list probably includes other tracks, so the marked trainee numbers may be off, and this program isn't compared with others until it's fixed. It's queued for another look. 2 people are also awaiting a match decision.
Fellows here publish most often with Núria Agustí, Roni Nitecki, and Jose Alejandro Rauh‐Hain at The University of Texas MD Anderson Cancer Center. How fellows publish ↓
- 12*
- Fellows
- 58%*
- Have published here
- 5.11*
- Papers per fellow-year
- 44%*
- Papers led by a fellow
- 83%*
- With a co-author at The University of Texas MD Anderson Cancer Center
Roster from the program's own page mdanderson.org, collected 2026-11-07: 12 current fellows in 4 classes. Something off? Tell us
Papers
By this program's leadership and fellows since 2022, 168 in all · 118 with a fellow author. Updated 2026-11-08.
- Survival After Risk-Reducing Mastectomy in Patients With Pathogenic Variants in BRCA1 and BRCA2Isabel Beshar et al. · JAMA Network Open · 2026 · PubMed
- The cervical microbiome in hispanic populations in Texas and Puerto Rico with and without cervical dysplasiaD'Shaunique Walters et al. · Scientific Reports · 2026 · PubMed
- ASSOCIATION OF HUMAN IMMUNODEFICIENCY VIRUS STATUS WITH CLINICAL PRESENTATION OF VULVAR CANCER IN MOZAMBIQUEShae Jansen et al. · International Journal of Gynecological Cancer · 2026
- DRIVERS OF UNPLANNED ACUTE CARE AFTER CHEMOTHERAPY IN GYNECOLOGIC CANCERKaren E. Haney et al. · International Journal of Gynecological Cancer · 2026
- ROBOTIC COMPARED TO LAPAROSCOPIC INTERVAL CYTOREDUCTIVE SURGERY IN STAGE III OVARIAN CANCER: AN ANALYSIS OF THE NATIONAL CANCER DATABASEGabriel Levin et al. · International Journal of Gynecological Cancer · 2026
- DELAYS TO CARE AMONG SCREEN-DETECTED EARLY-STAGE CERVICAL CANCER PATIENTS IN MOZAMBIQUEParisa Nicole Fallah et al. · International Journal of Gynecological Cancer · 2026
- MISSED OPPORTUNITIES FOR ENDOMETRIAL CANCER PREVENTION: LEVERAGING PATIENT EXPERIENCES TO INFORM DEVELOPMENT OF SHARED DECISION-MAKING TOOLS FOR THE PRIMARY PREVENTION OF ENDOMETRIAL CANCERKaren E. Haney et al. · International Journal of Gynecological Cancer · 2026
- OCCULT NODAL METASTASIS IN APPARENT EARLY LOW-GRADE SEROUS OVARIAN CARCINOMA: A META ANALYSIS.David Andres Viveros-Carreño et al. · International Journal of Gynecological Cancer · 2026
- PREOPERATIVE ANEMIA AS A MODIFIABLE RISK FACTOR IN GYNECOLOGIC ONCOLOGY: IDENTIFYING CANDIDATES FOR SURGICAL OPTIMIZATIONGavin G. Ovsak et al. · International Journal of Gynecological Cancer · 2026
- IMPLEMENTATION OF HPV SELF-COLLECTION AND FOLLOW-UP MANAGEMENT IN INDONESIAParisa Nicole Fallah et al. · International Journal of Gynecological Cancer · 2026
Trainees aren't named, for privacy. A paper is included when one of its authors is a current resident or fellow, or a graduate of the last two years, and it came out during their training.
How fellows publishauthor positions, co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 7 of 12 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Not compared with other programs yet. The trainee list probably includes other tracks. It's queued for another look.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Michaela Grinsfelder, M.D., M.P.H.PD | Endometrial and Cervical Cancer Treatments; PARP inhibition in cancer therapy | 5 | 15 | 0 | 0 | 0.25 |
12 trainees are counted above but never listed by name.
Gynecologic Oncology at The University of Texas MD Anderson Cancer Centershared by every program there, not this program's own
Institution-level: all gynecologic oncology publications from The University of Texas MD Anderson Cancer Center and affiliated institutions, since 2022. Updated 2026-11-08; refreshed daily.
Works per year · * 2026 so far
Gynecologic Oncology research topics at The University of Texas MD Anderson Cancer Center
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 1,237
- CAR-T cell therapy research 553
- Glioma Diagnosis and Treatment 406
- Pancreatic and Hepatic Oncology Research 397
- Sarcoma Diagnosis and Treatment 347
- Cancer survivorship and care 313
- Endometrial and Cervical Cancer Treatments 301
- Ovarian cancer diagnosis and treatment 300
Most cited at The University of Texas MD Anderson Cancer Center since 2024
All gynecologic oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 515
- Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumoursAshley M. Holder et al. · Nature reviews. Cancer · 2024 · PubMed · cited 319
- [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 studySimron Singh et al. · The Lancet · 2024 · PubMed · cited 441
- Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyAl B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 417
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateJulienne E. Bower et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 328
- Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P. D’Angelo et al. · The Lancet · 2024 · PubMed · cited 328
- Ribociclib plus Endocrine Therapy in Early Breast CancerDennis J. Slamon et al. · New England Journal of Medicine · 2024 · PubMed · cited 440
- Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton et al. · Cell · 2024 · PubMed · cited 570
- Unveiling the mechanisms and challenges of cancer drug resistanceSameer Ullah Khan et al. · Cell Communication and Signaling · 2024 · PubMed · cited 444
- Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialDavid Marín et al. · Nature Medicine · 2024 · PubMed · cited 560
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-texas-md-anderson-cancer-center-gyn-onc"><img src="https://openprograms.org/programs/university-texas-md-anderson-cancer-center-gyn-onc/badge.svg" alt="The University of Texas MD Anderson Cancer Center Gynecologic Oncology fellowship on OpenPrograms" height="20"></a><iframe src="https://openprograms.org/embed/university-texas-md-anderson-cancer-center-gyn-onc" title="Recent papers, The University of Texas MD Anderson Cancer Center Gynecologic Oncology fellowship" width="100%" height="520" style="border:0" loading="lazy"></iframe>Something wrong or missing on this page? Use the correction form below; changes show up in both.